In-Use Tolerance & Efficacy Study Under Dermatological Control of Sunscreen in Adults With Atopic Dermatitis Skin

CompletedOBSERVATIONAL
Enrollment

42

Participants

Timeline

Start Date

October 10, 2023

Primary Completion Date

February 9, 2024

Study Completion Date

February 9, 2024

Conditions
Atopic Dermatitis (AD)SCORAD Index(15-25)
Interventions
OTHER

Sunscreen RV4620A RP2552

Dermo-cosmetic product, Broadspectrum Sunscreen RV4620A RP2552, very high protection product Instructions for product use given to the subjects: Apply before and during sun exposure, at least twice daily. During sun exposure, applications must be renewed as often as necessary, in particular after swimming, perspiring, towelling, in order to ensure a good protection. On days of bad weather, apply the product in the morning and at the beginning of the afternoon.

Trial Locations (1)

72218

Insight Research, Quatre Bornes

All Listed Sponsors
lead

Pierre Fabre Dermo Cosmetique

INDUSTRY

NCT07194421 - In-Use Tolerance & Efficacy Study Under Dermatological Control of Sunscreen in Adults With Atopic Dermatitis Skin | Biotech Hunter | Biotech Hunter